Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €124.00 | €150.00 | 20.968% |
| Abeona Therapeutics Inc. | 6 | 1 | 2 | 0 | €4.62 | €19.31 | 317.955% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €77.50 | - | - |
| Aclaris Therapeutics Inc | 1 | 0 | 0 | 0 | €1.23 | €3.00 | 143.210% |
| Kura Oncology Inc | 1 | 0 | 0 | 0 | €19.05 | €20.00 | 4.987% |
| BeiGene Ltd ADR | 9 | 1 | 0 | 0 | €151.00 | €241.54 | 59.963% |
| AC Immune Ltd | 4 | 0 | 0 | 0 | €3.87 | €12.27 | 217.147% |
| Kezar Life Sciences | 6 | 0 | 1 | 0 | €0.61 | €18.49 | 2956.694% |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.52 | €6.00 | 70.455% |
| Agilent Technologies Inc. | 16 | 4 | 2 | 0 | €129.00 | €133.94 | 3.832% |
| Syros Pharmaceuticals Inc. | 7 | 1 | 0 | 0 | €5.80 | €13.70 | 136.264% |
| MannKind Corp. | 9 | 0 | 0 | 0 | €5.37 | €6.43 | 19.778% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €168.16 | €200.06 | 18.969% |
| Atossa Genetics Inc | 10 | 0 | 0 | 0 | €1.26 | €4.66 | 269.223% |
| Merck KGaA | 3 | 2 | 0 | 1 | €165.85 | €146.00 | -11.969% |
| Roche Holding AG ADR | 3 | 3 | 1 | 1 | €37.76 | €38.00 | 0.632% |
| CONMED Corp. | 11 | 2 | 1 | 1 | €64.50 | €100.05 | 55.109% |
| Incyte Corp. | 13 | 2 | 1 | 1 | €62.70 | €77.67 | 23.878% |
| Adaptimmune Therapeutics PLC ADR | 2 | 1 | 2 | 1 | €1.24 | €2.00 | 61.290% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 0 | 1 | €43.40 | €48.75 | 12.326% |
| Bruker Corp. | 10 | 2 | 1 | 1 | €62.84 | €82.85 | 31.849% |
| Eli Lilly Corp. | 62 | 1 | 7 | 1 | €730.10 | €824.47 | 12.925% |
| Inogen Inc. | 1 | 2 | 0 | 1 | €8.50 | €6.53 | -23.124% |
| Novavax Inc. | 4 | 1 | 0 | 1 | €11.36 | €22.18 | 95.217% |
| Bayer AG | 15 | 3 | 2 | 2 | €27.80 | €45.00 | 61.900% |